AR Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.05M | Hold |
11,620
| – | – | 0.19% | 77 |
|
|
2026
Q1 | $931K | Hold |
11,620
| – | – | 0.18% | 79 |
|
|
2025
Q4 | $991K | Hold |
11,620
| – | – | 0.2% | 76 |
|
|
2025
Q3 | $904K | Hold |
11,620
| – | – | 0.19% | 80 |
|
|
2025
Q2 | $909K | Hold |
11,620
| – | – | 0.2% | 78 |
|
|
2025
Q1 | $842K | Hold |
11,620
| – | – | 0.19% | 75 |
|
|
2024
Q4 | $860K | Hold |
11,620
| – | – | 0.19% | 75 |
|
|
2024
Q3 | $767K | Sell |
11,620
-750
| -6% | -$54.5K | 0.17% | 78 |
|
|
2024
Q2 | $1.14M | Hold |
12,370
| – | – | 0.28% | 66 |
|
|
2024
Q1 | $1.18M | Hold |
12,370
| – | – | 0.29% | 65 |
|
|
2023
Q4 | $943K | Sell |
12,370
-1,000
| -7% | -$69.6K | 0.25% | 68 |
|
|
2023
Q3 | $926K | Hold |
13,370
| – | – | 0.26% | 66 |
|
|
2023
Q2 | $1.26M | Hold |
13,370
| – | – | 0.34% | 58 |
|
|
2023
Q1 | $1.11M | Hold |
13,370
| – | – | 0.3% | 63 |
|
|
2022
Q4 | $998K | Buy |
13,370
+9,550
| +250% | +$736K | 0.28% | 61 |
|
|
2022
Q3 | $316K | Hold |
3,820
| – | – | 0.09% | 101 |
|
|
2022
Q2 | $363K | Hold |
3,820
| – | – | 0.1% | 100 |
|
|
2022
Q1 | $450K | Hold |
3,820
| – | – | 0.11% | 98 |
|
|
2021
Q4 | $495K | Sell |
3,820
-200
| -5% | -$23.3K | 0.13% | 97 |
|
|
2021
Q3 | $455K | Hold |
4,020
| – | – | 0.13% | 98 |
|
|
2021
Q2 | $416K | Hold |
4,020
| – | – | 0.12% | 98 |
|
|
2021
Q1 | $336K | Hold |
4,020
| – | – | 0.1% | 105 |
|
|
2020
Q4 | $367K | Hold |
4,020
| – | – | 0.12% | 100 |
|
|
2020
Q3 | $321K | Hold |
4,020
| – | – | 0.11% | 100 |
|
|
2020
Q2 | $278K | Hold |
4,020
| – | – | 0.11% | 105 |
|
|
2020
Q1 | $253K | Hold |
4,020
| – | – | 0.1% | 105 |
|
|
2019
Q4 | $313K | Hold |
4,020
| – | – | 0.1% | 104 |
|
|
2019
Q3 | $295K | Hold |
4,020
| – | – | 0.1% | 104 |
|
|
2019
Q2 | $248K | Hold |
4,020
| – | – | 0.09% | 111 |
|
|
2019
Q1 | $256K | Hold |
4,020
| – | – | 0.1% | 110 |
|
|
2018
Q4 | $205K | Hold |
4,020
| – | – | 0.09% | 110 |
|
|
2018
Q3 | $233K | Buy |
+4,020
| New | +$197K | 0.09% | 111 |
|
|
2016
Q4 | – | Sell |
-5,148
| Closed | -$207K | – | 119 |
|
|
2016
Q3 | $207K | Buy |
+5,148
| New | +$194K | 0.09% | 118 |
|
Other funds holding EW
VCM
VPM
AR Asset Management's EW Position: Q2 2026 in Review
AR Asset Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 11,620 shares worth $1.05M. The position accounts for 0.19% of the portfolio, ranked #77.
AR Asset Management first reported a position in EW in Q3 2016 and has held it in 33 quarters since. The position peaked at $1.26M in Q2 2023. 1,155 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- AR Asset Management held 11,620 shares of Edwards Lifesciences worth $1.05M as of Q2 2026.
- AR Asset Management left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up 0.19% of AR Asset Management's portfolio in Q2 2026, its #77 holding.
- AR Asset Management first reported a position in Edwards Lifesciences in Q3 2016 and has held it in 33 quarters since.
- AR Asset Management's Edwards Lifesciences position peaked at $1.26M in Q2 2023.
- 1,155 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on AR Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.